Claudio Fozza

13PUBLICATIONS
64CO-AUTHORS
NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Apr 10, 2026
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

Gabriele Gugliotta, Lisa Argnani, Martina Cantelli

|Oct 24, 2025
HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients.

Ilaria Cossu, Stefano Ruberto, Elisabetta Filippi

|Nov 25, 2020
Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone.

Antonio Carruale, Francesco Longu, Francesca Mura

|Mar 21, 2019
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.

Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese

|Apr 28, 2017
The burden of autoimmunity in myelodysplastic syndromes.

Claudio Fozza

Pageof 3

Frequent Collaborators

4 joint publications

Giovanni Caocci

4 joint publications

Massimo Breccia

2 joint publications

Nicola di Rienzo

2 joint publications

Alessandra Iurlo